ImmuCell Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	58	46	39	47	62	43
Market Cap Growth	22.96%	16.33%	-16.51%	-23.70%	44.31%	15.59%
Enterprise Value	68	58	54	51	62	48
Last Close Price	6.42	5.15	5.09	6.10	8.00	5.95
PE Ratio	24.87	-	-	-	-	-
PS Ratio	2.09	1.73	2.26	2.55	3.22	2.80
PB Ratio	1.95	1.67	1.58	1.56	1.90	1.52
P/TBV Ratio	1.96	1.68	1.59	1.56	1.91	1.53
P/FCF Ratio	81.18	-	-	-	-	-
P/OCF Ratio	29.19	128.23	-	-	64.91	32.62
EV/Sales Ratio	2.44	2.17	3.10	2.76	3.22	3.13
EV/EBITDA Ratio	12.48	39.63	-	65.78	22.78	49.62
EV/EBIT Ratio	24.78	-	-	-	240.62	-
EV/FCF Ratio	94.77	-	-	-	-	-
Debt / Equity Ratio	0.46	0.55	0.67	0.41	0.32	0.38
Debt / EBITDA Ratio	2.29	7.75	-	12.96	3.57	9.69
Debt / FCF Ratio	19.02	-	-	-	-	-
Net Debt / Equity Ratio	0.33	0.41	0.63	0.22	0.00	0.10
Net Debt / EBITDA Ratio	1.79	7.80	-6.27	8.60	0.03	2.88
Net Debt / FCF Ratio	13.59	-105.19	-2.39	-1.21	-0.05	-1.01
Asset Turnover	0.62	0.60	0.39	0.42	0.45	0.39
Inventory Turnover	1.85	2.43	1.89	2.26	4.09	3.68
Quick Ratio	1.63	1.72	0.76	2.47	5.09	4.44
Current Ratio	4.21	3.41	2.73	4.56	6.42	5.50
Return on Equity (ROE)	8.27%	-8.21%	-20.86%	-7.92%	-0.26%	-3.57%
Return on Assets (ROA)	3.79%	-1.73%	-7.36%	-2.39%	0.38%	-2.18%
Return on Invested Capital (ROIC)	7.00%	-3.10%	-13.43%	-4.90%	0.81%	-4.62%
Return on Capital Employed (ROCE)	6.60%	-3.00%	-13.20%	-4.10%	0.60%	-3.60%
Earnings Yield	4.00%	-4.70%	-14.64%	-5.28%	-0.13%	-2.38%
FCF Yield	1.23%	-0.24%	-16.64%	-11.68%	-2.67%	-6.42%
Buyback Yield / Dilution	-14.38%	-5.42%	-0.03%	-2.01%	-5.25%	-5.78%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q